Kriya Therapeutics
PrivateLast Round
Series D
Sep 10, 2025
Total Funding Raised
$1.08B
Company Overview
Kriya Therapeutics is a biotechnology company that designs and develops gene therapies for chronic diseases affecting large patient populations.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kriya Therapeutics Comparables
Compare Kriya Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ring Therapeutics | 82% | |
| 4DMT | 81% | |
| Frontera Therapeutics | 81% |
Kriya Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Sep 10, 2025 | ||||
| Series C Extension | Jul 26, 2023 | ||||
| Series C | May 16, 2022 | ||||
| Series B | Jul 14, 2021 | ||||
| Series A | May 12, 2020 | ||||
Seed | Oct 1, 2019 |
Key People
Founding team and executive leadership
Kriya Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Narya Capital | Series C, Series B, Series A, Series D |
| CAM Capital | Series C, Series B |
| Amplo | Series B, Series A |
| Patient Square Capital | Series C, Series C Extension, Series B, Series D |
| Hongkou Capital | Series B |
| Foresite Capital | Series C, Series B, Series A |
| PBM Capital Group | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 4, 2026
Hiring business owner for Dot Compliance eQMS platform.
- Sep 10, 2025
$320M Series D round completed.
Kriya Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Kriya Therapeutics's valuation, stock price, and market status.
Is Kriya Therapeutics a public or private company?
Kriya Therapeutics is a private company.
What is the current stock price of Kriya Therapeutics?
Kriya Therapeutics is a private company, so its shares have no public market price. Caplight tracks Kriya Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Kriya Therapeutics worth (valuation)?
Valuation information for Kriya Therapeutics is not publicly available.
Can I buy Kriya Therapeutics stock?
Kriya Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Kriya Therapeutics's last funding round?
Kriya Therapeutics's most recent funding round was Series D on September 10, 2025.
Who are the main investors in Kriya Therapeutics?
Key investors in Kriya Therapeutics include Amplo, Patient Square Capital, Foresite Capital, Premji Invest, Transhuman Capital.
Will Kriya Therapeutics IPO soon?
No public IPO plans have been announced for Kriya Therapeutics.
How can I track Kriya Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Kriya Therapeutics's shares on secondary markets.